
The scale of this procurement notice is tethered to two concurrent signals already published: the PLA's July 6 SLBM test (signaling continuous at-sea deterrence posture shift) and the July 8-9 US-Iran retaliation cycle now in active escalation. The JASSM/LRASM surge is not coincidental to these events — it reflects Pentagon planning for sustained high-tempo operations across two theaters simultaneously. If the Iran escalation sustains through Q4 2026, munitions consumption will compress the timeline for LRIP acceleration, forcing the Air Force to request an emergency supplemental by early 2027.
This procurement trajectory forces Raytheon Missiles & Fire Control to commit capital to production line scaling — the company must decide whether to fund capacity expansion on its own dime or demand government risk-sharing in the contract structure by September 2026, when the full RFP drops.
A 11,000-unit buy over 5-7 years averages 1,571 missiles annually; current production is estimated at 400-600 units per year across both variants. If Raytheon cannot or will not fund the ramp, the contract delays by 18-24 months while Congress appropriates LRIP tooling funds — a gap that exposes INDOPACOM to inventory depletion if Taiwan contingency operations begin before 2028. Watch the Q3 2026 earnings call for Raytheon's capital allocation guidance and any mention of government cost-sharing negotiations.
What is the current annual production rate for JASSM and LRASM combined, and does Raytheon have existing spare capacity at its Tucson facility, or does the 11,000-unit target require new factory construction?
Strategic intelligence, synthesized daily — with a public track record. Every call graded against what actually happened.